1. CMU Intellectual Repository

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Jun-2011Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trialTony S K Mok; Te Chun Hsia; Chun Ming Tsai; Kenneth Tsang; Gee Chen Chang; John Wen Cheng Chang; Sirisinha Thitiya; Virote Sriuranpong; Sumitra Thongprasert; Daniel Tt Chua; Nicola Moore; Christian Manegold
1-Jun-2011An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East AsiaJohn Wen Cheng Chang; Sumitra Thongprasert; Elaine Wright; Kenneth Tsang; Heung Tae Kim; Myung Ju Ahn; Joo Hang Kim; Jin Hyoung Kang; Sang We Kim; Stefan Walzer
1-Jan-2011Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)Sumitra Thongprasert; Emma Duffield; Nagahiro Saijo; Yi Long Wu; James Chih Hsin Yang; Da Tong Chu; Meilin Liao; Yuh Min Chen; Han Pin Kuo; Shunichi Negoro; Kwok Chi Lam; Alison Armour; Patrick Magill; Masahiro Fukuoka
1-Jan-2011Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approachManuel Salto-Tellez; Ming Sound Tsao; Jin Yuan Shih; Sumitra Thongprasert; Shun Lu; Gee Chen Chang; Joseph Siu Kie Au; Teh Ying Chou; Jong Seok Lee; Yuan Kai Shi; Ahmad Radzi; Jin Hyoung Kang; Sang We Kim; Soo Yong Tan; James Chih Hsin Yang
20-Jul-2011Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)Masahiro Fukuoka; Yi Long Wu; Sumitra Thongprasert; Patrapim Sunpaweravong; Swan Swan Leong; Virote Sriuranpong; Tsu Yi Chao; Kazuhiko Nakagawa; Da Tong Chu; Nagahiro Saijo
1-Dec-2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerSumitra Thongprasert; Unchalee Permsuwan; Chidchanok Ruengorn; Chaiyut Charoentum; Busyamas Chewaskulyong

Discover